Literature DB >> 10340614

Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production.

R J Cherney1, L Wang, D T Meyer, C B Xue, E C Arner, R A Copeland, M B Covington, K D Hardman, Z R Wasserman, B D Jaffee, C P Decicco.   

Abstract

Several macrocyclic, hydroxamate derivatives were synthesized and evaluated as inhibitors of matrix metalloproteinases (MMPs) and tumour necrosis factor-alpha (TNF-alpha) production. These macrocycles are anti-succinate based inhibitors linked from P1 to P2'. A variety of functionality was installed at the P1-P2' linkage, which gave inhibitors that displayed excellent MMP inhibition and good TNF-alpha suppression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340614     DOI: 10.1016/s0960-894x(99)00178-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

2.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.